世界の無嗅覚症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anosmia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3814
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、無嗅覚症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（特発性無嗅覚症、後天性無嗅覚症）、用途別市場規模（病院、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・無嗅覚症治療の市場動向
・企業の競争状況、市場シェア
・無嗅覚症治療の種類別市場規模と予測2016-2027（特発性無嗅覚症、後天性無嗅覚症）
・無嗅覚症治療の用途別市場規模と予測2016-2027（病院、専門診療所、その他）
・無嗅覚症治療の北米市場規模2016-2027（アメリカ、カナダ）
・無嗅覚症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・無嗅覚症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・無嗅覚症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・無嗅覚症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Mylan N.V、Pfizer, Inc.、Atom Pharma、Ranbaxy Laboratories Limited、Alde Medi Impex、GlaxoSmithkline plc、Sandoz (Novartis AG)、Inke S.A.、Taj Pharmaceuticals Limited、Sanofi）
・結論

Anosmia is the partial or complete loss of sense of smell. This loss could be temporary or permanent. Common conditions that irritate the nose’s lining, such as allergies or a cold, can lead to temporary anosmia.

Market Analysis and Insights: Global Anosmia Treatment Market
The global Anosmia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anosmia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anosmia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anosmia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anosmia Treatment market.

Global Anosmia Treatment Scope and Market Size
Anosmia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anosmia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Idiopathic Anosmia
Acquired Anosmia

Segment by Application
Hospitals
Specialty Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mylan N.V
Pfizer, Inc.
Atom Pharma
Ranbaxy Laboratories Limited
Alde Medi Impex
GlaxoSmithkline plc
Sandoz (Novartis AG)
Inke S.A.
Taj Pharmaceuticals Limited
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anosmia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Idiopathic Anosmia
1.2.3 Acquired Anosmia
1.3 Market by Application
1.3.1 Global Anosmia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anosmia Treatment Market Perspective (2016-2027)
2.2 Anosmia Treatment Growth Trends by Regions
2.2.1 Anosmia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anosmia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Anosmia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Anosmia Treatment Industry Dynamic
2.3.1 Anosmia Treatment Market Trends
2.3.2 Anosmia Treatment Market Drivers
2.3.3 Anosmia Treatment Market Challenges
2.3.4 Anosmia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anosmia Treatment Players by Revenue
3.1.1 Global Top Anosmia Treatment Players by Revenue (2016-2021)
3.1.2 Global Anosmia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Anosmia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anosmia Treatment Revenue
3.4 Global Anosmia Treatment Market Concentration Ratio
3.4.1 Global Anosmia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anosmia Treatment Revenue in 2020
3.5 Anosmia Treatment Key Players Head office and Area Served
3.6 Key Players Anosmia Treatment Product Solution and Service
3.7 Date of Enter into Anosmia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anosmia Treatment Breakdown Data by Type
4.1 Global Anosmia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Anosmia Treatment Forecasted Market Size by Type (2022-2027)

5 Anosmia Treatment Breakdown Data by Application
5.1 Global Anosmia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Anosmia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anosmia Treatment Market Size (2016-2027)
6.2 North America Anosmia Treatment Market Size by Type
6.2.1 North America Anosmia Treatment Market Size by Type (2016-2021)
6.2.2 North America Anosmia Treatment Market Size by Type (2022-2027)
6.2.3 North America Anosmia Treatment Market Size by Type (2016-2027)
6.3 North America Anosmia Treatment Market Size by Application
6.3.1 North America Anosmia Treatment Market Size by Application (2016-2021)
6.3.2 North America Anosmia Treatment Market Size by Application (2022-2027)
6.3.3 North America Anosmia Treatment Market Size by Application (2016-2027)
6.4 North America Anosmia Treatment Market Size by Country
6.4.1 North America Anosmia Treatment Market Size by Country (2016-2021)
6.4.2 North America Anosmia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anosmia Treatment Market Size (2016-2027)
7.2 Europe Anosmia Treatment Market Size by Type
7.2.1 Europe Anosmia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Anosmia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Anosmia Treatment Market Size by Type (2016-2027)
7.3 Europe Anosmia Treatment Market Size by Application
7.3.1 Europe Anosmia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Anosmia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Anosmia Treatment Market Size by Application (2016-2027)
7.4 Europe Anosmia Treatment Market Size by Country
7.4.1 Europe Anosmia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Anosmia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anosmia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Anosmia Treatment Market Size by Type
8.2.1 Asia-Pacific Anosmia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anosmia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anosmia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Anosmia Treatment Market Size by Application
8.3.1 Asia-Pacific Anosmia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anosmia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anosmia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Anosmia Treatment Market Size by Region
8.4.1 Asia-Pacific Anosmia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anosmia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anosmia Treatment Market Size (2016-2027)
9.2 Latin America Anosmia Treatment Market Size by Type
9.2.1 Latin America Anosmia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Anosmia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Anosmia Treatment Market Size by Type (2016-2027)
9.3 Latin America Anosmia Treatment Market Size by Application
9.3.1 Latin America Anosmia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Anosmia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Anosmia Treatment Market Size by Application (2016-2027)
9.4 Latin America Anosmia Treatment Market Size by Country
9.4.1 Latin America Anosmia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Anosmia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anosmia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Anosmia Treatment Market Size by Type
10.2.1 Middle East & Africa Anosmia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anosmia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anosmia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Anosmia Treatment Market Size by Application
10.3.1 Middle East & Africa Anosmia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anosmia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anosmia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Anosmia Treatment Market Size by Country
10.4.1 Middle East & Africa Anosmia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anosmia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mylan N.V
11.1.1 Mylan N.V Company Details
11.1.2 Mylan N.V Business Overview
11.1.3 Mylan N.V Anosmia Treatment Introduction
11.1.4 Mylan N.V Revenue in Anosmia Treatment Business (2016-2021)
11.1.5 Mylan N.V Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Details
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Anosmia Treatment Introduction
11.2.4 Pfizer, Inc. Revenue in Anosmia Treatment Business (2016-2021)
11.2.5 Pfizer, Inc. Recent Development
11.3 Atom Pharma
11.3.1 Atom Pharma Company Details
11.3.2 Atom Pharma Business Overview
11.3.3 Atom Pharma Anosmia Treatment Introduction
11.3.4 Atom Pharma Revenue in Anosmia Treatment Business (2016-2021)
11.3.5 Atom Pharma Recent Development
11.4 Ranbaxy Laboratories Limited
11.4.1 Ranbaxy Laboratories Limited Company Details
11.4.2 Ranbaxy Laboratories Limited Business Overview
11.4.3 Ranbaxy Laboratories Limited Anosmia Treatment Introduction
11.4.4 Ranbaxy Laboratories Limited Revenue in Anosmia Treatment Business (2016-2021)
11.4.5 Ranbaxy Laboratories Limited Recent Development
11.5 Alde Medi Impex
11.5.1 Alde Medi Impex Company Details
11.5.2 Alde Medi Impex Business Overview
11.5.3 Alde Medi Impex Anosmia Treatment Introduction
11.5.4 Alde Medi Impex Revenue in Anosmia Treatment Business (2016-2021)
11.5.5 Alde Medi Impex Recent Development
11.6 GlaxoSmithkline plc
11.6.1 GlaxoSmithkline plc Company Details
11.6.2 GlaxoSmithkline plc Business Overview
11.6.3 GlaxoSmithkline plc Anosmia Treatment Introduction
11.6.4 GlaxoSmithkline plc Revenue in Anosmia Treatment Business (2016-2021)
11.6.5 GlaxoSmithkline plc Recent Development
11.7 Sandoz (Novartis AG)
11.7.1 Sandoz (Novartis AG) Company Details
11.7.2 Sandoz (Novartis AG) Business Overview
11.7.3 Sandoz (Novartis AG) Anosmia Treatment Introduction
11.7.4 Sandoz (Novartis AG) Revenue in Anosmia Treatment Business (2016-2021)
11.7.5 Sandoz (Novartis AG) Recent Development
11.8 Inke S.A.
11.8.1 Inke S.A. Company Details
11.8.2 Inke S.A. Business Overview
11.8.3 Inke S.A. Anosmia Treatment Introduction
11.8.4 Inke S.A. Revenue in Anosmia Treatment Business (2016-2021)
11.8.5 Inke S.A. Recent Development
11.9 Taj Pharmaceuticals Limited
11.9.1 Taj Pharmaceuticals Limited Company Details
11.9.2 Taj Pharmaceuticals Limited Business Overview
11.9.3 Taj Pharmaceuticals Limited Anosmia Treatment Introduction
11.9.4 Taj Pharmaceuticals Limited Revenue in Anosmia Treatment Business (2016-2021)
11.9.5 Taj Pharmaceuticals Limited Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Anosmia Treatment Introduction
11.10.4 Sanofi Revenue in Anosmia Treatment Business (2016-2021)
11.10.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anosmia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Idiopathic Anosmia
Table 3. Key Players of Acquired Anosmia
Table 4. Global Anosmia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anosmia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anosmia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anosmia Treatment Market Share by Regions (2016-2021)
Table 8. Global Anosmia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anosmia Treatment Market Share by Regions (2022-2027)
Table 10. Anosmia Treatment Market Trends
Table 11. Anosmia Treatment Market Drivers
Table 12. Anosmia Treatment Market Challenges
Table 13. Anosmia Treatment Market Restraints
Table 14. Global Anosmia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anosmia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Anosmia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anosmia Treatment as of 2020)
Table 17. Ranking of Global Top Anosmia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anosmia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anosmia Treatment Product Solution and Service
Table 21. Date of Enter into Anosmia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anosmia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anosmia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Anosmia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anosmia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anosmia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anosmia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Anosmia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anosmia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anosmia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anosmia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anosmia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anosmia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anosmia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anosmia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anosmia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anosmia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anosmia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anosmia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anosmia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anosmia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anosmia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anosmia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anosmia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anosmia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anosmia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anosmia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anosmia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anosmia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anosmia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anosmia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anosmia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anosmia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anosmia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anosmia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anosmia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anosmia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anosmia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anosmia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Mylan N.V Company Details
Table 62. Mylan N.V Business Overview
Table 63. Mylan N.V Anosmia Treatment Product
Table 64. Mylan N.V Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 65. Mylan N.V Recent Development
Table 66. Pfizer, Inc. Company Details
Table 67. Pfizer, Inc. Business Overview
Table 68. Pfizer, Inc. Anosmia Treatment Product
Table 69. Pfizer, Inc. Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer, Inc. Recent Development
Table 71. Atom Pharma Company Details
Table 72. Atom Pharma Business Overview
Table 73. Atom Pharma Anosmia Treatment Product
Table 74. Atom Pharma Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 75. Atom Pharma Recent Development
Table 76. Ranbaxy Laboratories Limited Company Details
Table 77. Ranbaxy Laboratories Limited Business Overview
Table 78. Ranbaxy Laboratories Limited Anosmia Treatment Product
Table 79. Ranbaxy Laboratories Limited Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 80. Ranbaxy Laboratories Limited Recent Development
Table 81. Alde Medi Impex Company Details
Table 82. Alde Medi Impex Business Overview
Table 83. Alde Medi Impex Anosmia Treatment Product
Table 84. Alde Medi Impex Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 85. Alde Medi Impex Recent Development
Table 86. GlaxoSmithkline plc Company Details
Table 87. GlaxoSmithkline plc Business Overview
Table 88. GlaxoSmithkline plc Anosmia Treatment Product
Table 89. GlaxoSmithkline plc Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithkline plc Recent Development
Table 91. Sandoz (Novartis AG) Company Details
Table 92. Sandoz (Novartis AG) Business Overview
Table 93. Sandoz (Novartis AG) Anosmia Treatment Product
Table 94. Sandoz (Novartis AG) Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 95. Sandoz (Novartis AG) Recent Development
Table 96. Inke S.A. Company Details
Table 97. Inke S.A. Business Overview
Table 98. Inke S.A. Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 99. Inke S.A. Recent Development
Table 100. Taj Pharmaceuticals Limited Company Details
Table 101. Taj Pharmaceuticals Limited Business Overview
Table 102. Taj Pharmaceuticals Limited Anosmia Treatment Product
Table 103. Taj Pharmaceuticals Limited Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 104. Taj Pharmaceuticals Limited Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Anosmia Treatment Product
Table 108. Sanofi Revenue in Anosmia Treatment Business (2016-2021) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anosmia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Idiopathic Anosmia Features
Figure 3. Acquired Anosmia Features
Figure 4. Global Anosmia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Anosmia Treatment Report Years Considered
Figure 9. Global Anosmia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Anosmia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anosmia Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Anosmia Treatment Market Share by Regions (2022-2027)
Figure 13. Global Anosmia Treatment Market Share by Players in 2020
Figure 14. Global Top Anosmia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anosmia Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Anosmia Treatment Revenue in 2020
Figure 16. Global Anosmia Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Anosmia Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Anosmia Treatment Market Share by Type (2016-2027)
Figure 20. North America Anosmia Treatment Market Share by Application (2016-2027)
Figure 21. North America Anosmia Treatment Market Share by Country (2016-2027)
Figure 22. United States Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anosmia Treatment Market Share by Type (2016-2027)
Figure 26. Europe Anosmia Treatment Market Share by Application (2016-2027)
Figure 27. Europe Anosmia Treatment Market Share by Country (2016-2027)
Figure 28. Germany Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anosmia Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Anosmia Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Anosmia Treatment Market Share by Region (2016-2027)
Figure 38. China Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anosmia Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Anosmia Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Anosmia Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anosmia Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Anosmia Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Anosmia Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Anosmia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Mylan N.V Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 58. Pfizer, Inc. Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 59. Atom Pharma Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 60. Ranbaxy Laboratories Limited Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 61. Alde Medi Impex Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 62. GlaxoSmithkline plc Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 63. Sandoz (Novartis AG) Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 64. Inke S.A. Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 65. Taj Pharmaceuticals Limited Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Anosmia Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の後天性血友病治療市場規模・現状・予測（2021年-2027年） Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. Market Analysis and Insights: Global Acquired Hemophilia Treatment Market The global Acquired Hemophilia Treatment market size is projected…
世界の慢性特発性便秘治療市場規模・現状・予測（2021年-2027年） Chronic idiopathic constipation is a highly prevalent functional bowel disorder that affects millions of individuals worldwide. Some of the major factors that contribute to the burgeoning number of patients suffering from chronic idiopathic constipation include sedentary lifestyle, increasing usage …
世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Cystic Kidney Disease Treatment Drugs Market The global Acquired Cystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
世界のICU（集中治療室）における急性腎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global ICU-acquired Acute Kidney Treatment Market The global ICU-acquired Acute Kidney Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
世界の特発性過眠症治療市場規模・現状・予測（2021年-2027年） Idiopathic hypersomnia (IH) is a rare sleep disorder marked by an over sleeping duration time during the day even after a longer sleeping hours of night sleep. People with idiopathic hypersomnia sleep normal or for long hours each night but still feel excessively sleepy during the day. Idiopathic hy…